img

Global Menopausal Hormone Therapy Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Menopausal Hormone Therapy Market Research Report 2024

Menopausal hormone therapy (MHT) is a treatment that uses hormones to relieve the symptoms of menopause. Menopause is a natural process that occurs when a woman's ovaries stop producing estrogen and progesterone. This can cause a variety of symptoms, including hot flashes, night sweats, vaginal dryness, mood swings, and difficulty sleeping.
According to MRAResearch’s new survey, global Menopausal Hormone Therapy market is projected to reach US$ 35810 million in 2033, increasing from US$ 23500 million in 2022, with the CAGR of 6.1% during the period of 2023 to 2033.
The menopausal hormone therapy (MHT) market is expected to grow significantly in the coming years, driven by a number of factors, including
Rising awareness of the benefits of menopausal hormone therapyThere is a growing awareness of the benefits of menopausal hormone therapy, such as relief of menopausal symptoms, reduced risk of osteoporosis, and improved cardiovascular health. This is also driving the demand for menopausal hormone therapy.
Changing social normsSocial norms are changing around menopause, and women are becoming more open to discussing their symptoms and seeking treatment. This is also driving the demand for menopausal hormone therapy.
The North American region is expected to be the largest market for menopausal hormone therapy, followed by Europe and the Asia Pacific region. The growth of the market in the North American region is being driven by the high prevalence of menopause and the easy availability of menopausal hormone therapy products.
Overall, the menopausal hormone therapy market is expected to grow significantly in the coming years, driven by increasing population of menopausal women, rising awareness of the benefits of menopausal hormone therapy, and changing social norms.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Menopausal Hormone Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
Pfizer
AbbVie
Novo Nordisk
Merck KGaA
Mylan
Bayer
Teva
Novartis
Abbott
Roche
Endo International
Ipsen
ANI Pharmaceuticals
TherapeuticsMD
Segment by Type
Estrogen
Progesterone

Segment by Application


Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Menopausal Hormone Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Menopausal Hormone Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Estrogen
1.2.3 Progesterone
1.3 Market by Application
1.3.1 Global Menopausal Hormone Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Menopausal Hormone Therapy Market Perspective (2018-2033)
2.2 Menopausal Hormone Therapy Growth Trends by Region
2.2.1 Global Menopausal Hormone Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Menopausal Hormone Therapy Historic Market Size by Region (2018-2023)
2.2.3 Menopausal Hormone Therapy Forecasted Market Size by Region (2024-2033)
2.3 Menopausal Hormone Therapy Market Dynamics
2.3.1 Menopausal Hormone Therapy Industry Trends
2.3.2 Menopausal Hormone Therapy Market Drivers
2.3.3 Menopausal Hormone Therapy Market Challenges
2.3.4 Menopausal Hormone Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Menopausal Hormone Therapy Players by Revenue
3.1.1 Global Top Menopausal Hormone Therapy Players by Revenue (2018-2023)
3.1.2 Global Menopausal Hormone Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Menopausal Hormone Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Menopausal Hormone Therapy Revenue
3.4 Global Menopausal Hormone Therapy Market Concentration Ratio
3.4.1 Global Menopausal Hormone Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Menopausal Hormone Therapy Revenue in 2022
3.5 Menopausal Hormone Therapy Key Players Head office and Area Served
3.6 Key Players Menopausal Hormone Therapy Product Solution and Service
3.7 Date of Enter into Menopausal Hormone Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Menopausal Hormone Therapy Breakdown Data by Type
4.1 Global Menopausal Hormone Therapy Historic Market Size by Type (2018-2023)
4.2 Global Menopausal Hormone Therapy Forecasted Market Size by Type (2024-2033)
5 Menopausal Hormone Therapy Breakdown Data by Application
5.1 Global Menopausal Hormone Therapy Historic Market Size by Application (2018-2023)
5.2 Global Menopausal Hormone Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Menopausal Hormone Therapy Market Size (2018-2033)
6.2 North America Menopausal Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Menopausal Hormone Therapy Market Size by Country (2018-2023)
6.4 North America Menopausal Hormone Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Menopausal Hormone Therapy Market Size (2018-2033)
7.2 Europe Menopausal Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Menopausal Hormone Therapy Market Size by Country (2018-2023)
7.4 Europe Menopausal Hormone Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Menopausal Hormone Therapy Market Size (2018-2033)
8.2 Asia-Pacific Menopausal Hormone Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Menopausal Hormone Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Menopausal Hormone Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Menopausal Hormone Therapy Market Size (2018-2033)
9.2 Latin America Menopausal Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Menopausal Hormone Therapy Market Size by Country (2018-2023)
9.4 Latin America Menopausal Hormone Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Menopausal Hormone Therapy Market Size (2018-2033)
10.2 Middle East & Africa Menopausal Hormone Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Menopausal Hormone Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Menopausal Hormone Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Menopausal Hormone Therapy Introduction
11.1.4 Eli Lilly Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Menopausal Hormone Therapy Introduction
11.2.4 Pfizer Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.2.5 Pfizer Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Menopausal Hormone Therapy Introduction
11.3.4 AbbVie Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Detail
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Menopausal Hormone Therapy Introduction
11.4.4 Novo Nordisk Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.4.5 Novo Nordisk Recent Development
11.5 Merck KGaA
11.5.1 Merck KGaA Company Detail
11.5.2 Merck KGaA Business Overview
11.5.3 Merck KGaA Menopausal Hormone Therapy Introduction
11.5.4 Merck KGaA Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.5.5 Merck KGaA Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan Menopausal Hormone Therapy Introduction
11.6.4 Mylan Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.6.5 Mylan Recent Development
11.7 Bayer
11.7.1 Bayer Company Detail
11.7.2 Bayer Business Overview
11.7.3 Bayer Menopausal Hormone Therapy Introduction
11.7.4 Bayer Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.7.5 Bayer Recent Development
11.8 Teva
11.8.1 Teva Company Detail
11.8.2 Teva Business Overview
11.8.3 Teva Menopausal Hormone Therapy Introduction
11.8.4 Teva Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.8.5 Teva Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Menopausal Hormone Therapy Introduction
11.9.4 Novartis Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.9.5 Novartis Recent Development
11.10 Abbott
11.10.1 Abbott Company Detail
11.10.2 Abbott Business Overview
11.10.3 Abbott Menopausal Hormone Therapy Introduction
11.10.4 Abbott Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.10.5 Abbott Recent Development
11.11 Roche
11.11.1 Roche Company Detail
11.11.2 Roche Business Overview
11.11.3 Roche Menopausal Hormone Therapy Introduction
11.11.4 Roche Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.11.5 Roche Recent Development
11.12 Endo International
11.12.1 Endo International Company Detail
11.12.2 Endo International Business Overview
11.12.3 Endo International Menopausal Hormone Therapy Introduction
11.12.4 Endo International Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.12.5 Endo International Recent Development
11.13 Ipsen
11.13.1 Ipsen Company Detail
11.13.2 Ipsen Business Overview
11.13.3 Ipsen Menopausal Hormone Therapy Introduction
11.13.4 Ipsen Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.13.5 Ipsen Recent Development
11.14 ANI Pharmaceuticals
11.14.1 ANI Pharmaceuticals Company Detail
11.14.2 ANI Pharmaceuticals Business Overview
11.14.3 ANI Pharmaceuticals Menopausal Hormone Therapy Introduction
11.14.4 ANI Pharmaceuticals Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.14.5 ANI Pharmaceuticals Recent Development
11.15 TherapeuticsMD
11.15.1 TherapeuticsMD Company Detail
11.15.2 TherapeuticsMD Business Overview
11.15.3 TherapeuticsMD Menopausal Hormone Therapy Introduction
11.15.4 TherapeuticsMD Revenue in Menopausal Hormone Therapy Business (2018-2023)
11.15.5 TherapeuticsMD Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Menopausal Hormone Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Estrogen
Table 3. Key Players of Progesterone
Table 4. Global Menopausal Hormone Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Menopausal Hormone Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Menopausal Hormone Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Menopausal Hormone Therapy Market Share by Region (2018-2023)
Table 8. Global Menopausal Hormone Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Menopausal Hormone Therapy Market Share by Region (2024-2033)
Table 10. Menopausal Hormone Therapy Market Trends
Table 11. Menopausal Hormone Therapy Market Drivers
Table 12. Menopausal Hormone Therapy Market Challenges
Table 13. Menopausal Hormone Therapy Market Restraints
Table 14. Global Menopausal Hormone Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Menopausal Hormone Therapy Market Share by Players (2018-2023)
Table 16. Global Top Menopausal Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopausal Hormone Therapy as of 2022)
Table 17. Ranking of Global Top Menopausal Hormone Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Menopausal Hormone Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Menopausal Hormone Therapy Product Solution and Service
Table 21. Date of Enter into Menopausal Hormone Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Menopausal Hormone Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Menopausal Hormone Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Menopausal Hormone Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Menopausal Hormone Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Menopausal Hormone Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Menopausal Hormone Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Menopausal Hormone Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Menopausal Hormone Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America Menopausal Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Menopausal Hormone Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Menopausal Hormone Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Menopausal Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Menopausal Hormone Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Menopausal Hormone Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Menopausal Hormone Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Menopausal Hormone Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Menopausal Hormone Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Menopausal Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Menopausal Hormone Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Menopausal Hormone Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Menopausal Hormone Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Menopausal Hormone Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Menopausal Hormone Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Eli Lilly Company Detail
Table 47. Eli Lilly Business Overview
Table 48. Eli Lilly Menopausal Hormone Therapy Product
Table 49. Eli Lilly Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 50. Eli Lilly Recent Development
Table 51. Pfizer Company Detail
Table 52. Pfizer Business Overview
Table 53. Pfizer Menopausal Hormone Therapy Product
Table 54. Pfizer Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 55. Pfizer Recent Development
Table 56. AbbVie Company Detail
Table 57. AbbVie Business Overview
Table 58. AbbVie Menopausal Hormone Therapy Product
Table 59. AbbVie Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 60. AbbVie Recent Development
Table 61. Novo Nordisk Company Detail
Table 62. Novo Nordisk Business Overview
Table 63. Novo Nordisk Menopausal Hormone Therapy Product
Table 64. Novo Nordisk Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 65. Novo Nordisk Recent Development
Table 66. Merck KGaA Company Detail
Table 67. Merck KGaA Business Overview
Table 68. Merck KGaA Menopausal Hormone Therapy Product
Table 69. Merck KGaA Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 70. Merck KGaA Recent Development
Table 71. Mylan Company Detail
Table 72. Mylan Business Overview
Table 73. Mylan Menopausal Hormone Therapy Product
Table 74. Mylan Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 75. Mylan Recent Development
Table 76. Bayer Company Detail
Table 77. Bayer Business Overview
Table 78. Bayer Menopausal Hormone Therapy Product
Table 79. Bayer Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Teva Company Detail
Table 82. Teva Business Overview
Table 83. Teva Menopausal Hormone Therapy Product
Table 84. Teva Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 85. Teva Recent Development
Table 86. Novartis Company Detail
Table 87. Novartis Business Overview
Table 88. Novartis Menopausal Hormone Therapy Product
Table 89. Novartis Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Abbott Company Detail
Table 92. Abbott Business Overview
Table 93. Abbott Menopausal Hormone Therapy Product
Table 94. Abbott Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 95. Abbott Recent Development
Table 96. Roche Company Detail
Table 97. Roche Business Overview
Table 98. Roche Menopausal Hormone Therapy Product
Table 99. Roche Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Endo International Company Detail
Table 102. Endo International Business Overview
Table 103. Endo International Menopausal Hormone Therapy Product
Table 104. Endo International Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 105. Endo International Recent Development
Table 106. Ipsen Company Detail
Table 107. Ipsen Business Overview
Table 108. Ipsen Menopausal Hormone Therapy Product
Table 109. Ipsen Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 110. Ipsen Recent Development
Table 111. ANI Pharmaceuticals Company Detail
Table 112. ANI Pharmaceuticals Business Overview
Table 113. ANI Pharmaceuticals Menopausal Hormone Therapy Product
Table 114. ANI Pharmaceuticals Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 115. ANI Pharmaceuticals Recent Development
Table 116. TherapeuticsMD Company Detail
Table 117. TherapeuticsMD Business Overview
Table 118. TherapeuticsMD Menopausal Hormone Therapy Product
Table 119. TherapeuticsMD Revenue in Menopausal Hormone Therapy Business (2018-2023) & (US$ Million)
Table 120. TherapeuticsMD Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Menopausal Hormone Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Menopausal Hormone Therapy Market Share by Type: 2022 VS 2033
Figure 3. Estrogen Features
Figure 4. Progesterone Features
Figure 5. Global Menopausal Hormone Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Menopausal Hormone Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Menopausal Hormone Therapy Report Years Considered
Figure 11. Global Menopausal Hormone Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Menopausal Hormone Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Menopausal Hormone Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Menopausal Hormone Therapy Market Share by Players in 2022
Figure 15. Global Top Menopausal Hormone Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Menopausal Hormone Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Menopausal Hormone Therapy Revenue in 2022
Figure 17. North America Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Menopausal Hormone Therapy Market Share by Country (2018-2033)
Figure 19. United States Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Menopausal Hormone Therapy Market Share by Country (2018-2033)
Figure 23. Germany Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Menopausal Hormone Therapy Market Share by Region (2018-2033)
Figure 31. China Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Menopausal Hormone Therapy Market Share by Country (2018-2033)
Figure 39. Mexico Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Menopausal Hormone Therapy Market Share by Country (2018-2033)
Figure 43. Turkey Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Menopausal Hormone Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Eli Lilly Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 46. Pfizer Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 47. AbbVie Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 48. Novo Nordisk Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 49. Merck KGaA Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 50. Mylan Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 52. Teva Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 54. Abbott Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 55. Roche Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 56. Endo International Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 57. Ipsen Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 58. ANI Pharmaceuticals Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 59. TherapeuticsMD Revenue Growth Rate in Menopausal Hormone Therapy Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed